Due to the complexity of the connection between NF-κB and HIF-1α, it is difficult to appreciate and deconstruct this crosstalk, which necessitate the exploration of various signaling pathways and the possible positive and negative feedback loops for effective targeting and therapy in BC. The gene discussed is NFKB1; the disease is breast cancer.